These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22198252)

  • 1. Screening for disease in the newborn: the evidence base for blood-spot screening.
    Wilcken B
    Pathology; 2012 Feb; 44(2):73-9. PubMed ID: 22198252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass neonatal screening using biological testing].
    Ardaillou R; Le Gall JY;
    Gynecol Obstet Fertil; 2007 Apr; 35(4):367-74. PubMed ID: 17400505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Generalized neonatal screening based on laboratory tests].
    Ardaillou R; Le Gall JY
    Bull Acad Natl Med; 2006 Nov; 190(8):1745-59. PubMed ID: 17650757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening.
    Wilcken B; Wiley V
    Pathology; 2008 Feb; 40(2):104-15. PubMed ID: 18203033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry in clinical chemistry: the case of newborn screening.
    la Marca G
    J Pharm Biomed Anal; 2014 Dec; 101():174-82. PubMed ID: 24844843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.
    Zaffanello M; Maffeis C; Zamboni G
    J Perinat Med; 2005; 33(3):246-51. PubMed ID: 15914349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening fact sheets.
    Kaye CI; ; Accurso F; La Franchi S; Lane PA; Hope N; Sonya P; G Bradley S; Michele A LP
    Pediatrics; 2006 Sep; 118(3):e934-63. PubMed ID: 16950973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of newborn screening.
    Levy PA
    J Dev Behav Pediatr; 2010 Sep; 31(7):622-31. PubMed ID: 20814260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
    Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technologies extend the scope of newborn blood-spot screening, but old problems remain unresolved.
    Pollitt RJ
    Acta Paediatr; 2010 Dec; 99(12):1766-72. PubMed ID: 20645927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The advisory report 'Neonatal screening' from the Health Council of The Netherlands].
    Bolhuis PA; Page-Christiaens GC
    Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2857-60. PubMed ID: 16398167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening and monitoring system in Taiwan.
    Hwu WL; Huang AC; Chen JS; Hsiao KJ; Tsai WY
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():91-3. PubMed ID: 15906707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
    Peter M; Janzen N; Sander S; Korsch E; Riepe FG; Sander J
    Horm Res; 2008; 69(4):253-6. PubMed ID: 18204274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update: newborn screening for endocrinopathies.
    Pass KA; Neto EC
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):827-37. PubMed ID: 19944295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental tolerance of false-positive newborn screening results.
    Prosser LA; Ladapo JA; Rusinak D; Waisbren SE
    Arch Pediatr Adolesc Med; 2008 Sep; 162(9):870-6. PubMed ID: 18762606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.